ETON
Eton Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$58.45
−2.42%Forward multiples
Based on analyst estimates
- P/E forward
- 32.60x
- P/E 2026E
- 46.11x
- P/E 2027E
- 23.66x
- P/E 2028E
- 16.91x
- P/S forward
- 8.68x
Trailing multiples
Trailing twelve months
- P/E TTM
- 125.70x
- PEG TTM
- 0.44x
- Price / book
- 35.86x
- Price / sales
- 15.82x
- Price / cash flow
- 110.39x
Enterprise value
- Enterprise value
- $1.7B
- EV / sales
- 15.84x
- EV / EBITDA
- 90.11x
- EV / EBIT
- 102.57x
- Market cap
- $1.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026